These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35387670)

  • 1. PAX2, PAX8, and PR are correlated with ovarian seromucinous borderline tumor with endometriosis.
    Yun BS; Won S; Kim JH; Lee N; Kim M; Kim MK; Kim ML; Jung YW; Kim JY; Seong SJ; Shin E
    J Ovarian Res; 2022 Apr; 15(1):41. PubMed ID: 35387670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathologic Features and the Loss of ARID1A Expression in Ovarian Seromucinous Borderline Tumors and Seromucinous Carcinomas.
    Ok Atılgan A; Özen Ö; Haberal Reyhan AN; Ayhan A
    Int J Surg Pathol; 2023 Jun; 31(4):398-408. PubMed ID: 36452965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PAX2, PAX8 and CDX2 Expression in Metastatic Mucinous, Primary Ovarian Mucinous and Seromucinous Tumors and Review of the Literature.
    Ates Ozdemir D; Usubutun A
    Pathol Oncol Res; 2016 Jul; 22(3):593-9. PubMed ID: 26797858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian seromucinous carcinoma: report of a series of a newly categorized and uncommon neoplasm.
    Taylor J; McCluggage WG
    Am J Surg Pathol; 2015 Jul; 39(7):983-92. PubMed ID: 25723110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
    Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
    Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
    [No Abstract]   [Full Text] [Related]  

  • 6. [Expression of ARID1A in ovarian seromucinous neoplasms and its clinicopathological significance].
    Ding XH; Tian X; Wang LQ; Wang Y; Liu AJ
    Zhonghua Bing Li Xue Za Zhi; 2020 Jun; 49(6):588-593. PubMed ID: 32486536
    [No Abstract]   [Full Text] [Related]  

  • 7. Ovarian seromucinous tumors: clinicopathological features of 10 cases with a detailed review of the literature.
    Idrees R; Din NU; Siddique S; Fatima S; Abdul-Ghafar J; Ahmad Z
    J Ovarian Res; 2021 Mar; 14(1):47. PubMed ID: 33736662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seromucinous ovarian tumor A comparison with the rest of ovarian epithelial tumors.
    Karpathiou G; Chauleur C; Corsini T; Venet M; Habougit C; Honeyman F; Forest F; Peoc'h M
    Ann Diagn Pathol; 2017 Apr; 27():28-33. PubMed ID: 28325358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole-tumor ADC histogram analysis for differentiating endometriosis-related tumors: seromucinous borderline tumor, clear cell carcinoma and endometrioid carcinoma.
    Lu J; Zhao S; Ma F; Li H; Li Y; Qiang J
    Abdom Radiol (NY); 2023 Feb; 48(2):724-732. PubMed ID: 36401131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic performance of MR imaging findings and quantitative values in the differentiation of seromucinous borderline tumour from endometriosis-related malignant ovarian tumour.
    Kurata Y; Kido A; Moribata Y; Kameyama K; Himoto Y; Minamiguchi S; Konishi I; Togashi K
    Eur Radiol; 2017 Apr; 27(4):1695-1703. PubMed ID: 27553934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive genomic profiling reveals ubiquitous KRAS mutations and frequent PIK3CA mutations in ovarian seromucinous borderline tumor.
    Wu RC; Chen SJ; Chen HC; Tan KT; Jung SM; Lin CY; Chao AS; Huang KG; Chou HH; Chang TC; Chao A; Lai CH
    Mod Pathol; 2020 Dec; 33(12):2534-2543. PubMed ID: 32616873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovarian Seromucinous Borderline Tumors Are Histologically Different from Mucinous Borderline Tumors.
    Hada T; Miyamoto M; Ishibashi H; Kawauchi H; Soyama H; Matsuura H; Sakamoto T; Kakimoto S; Aoyama T; Iwahashi H; Suzuki R; Tsuda H; Takano M
    In Vivo; 2020; 34(3):1341-1346. PubMed ID: 32354928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocervical-type mucinous borderline tumors are related to endometrioid tumors based on mutation and loss of expression of ARID1A.
    Wu CH; Mao TL; Vang R; Ayhan A; Wang TL; Kurman RJ; Shih IeM
    Int J Gynecol Pathol; 2012 Jul; 31(4):297-303. PubMed ID: 22653341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three cases of seromucinous carcinoma of the ovary arising in endometriotic cysts.
    Taga Y; Chigusa Y; Minamiguchi S; Kido A; Horikawa N; Horie A; Hamanishi J; Kondoh E; Mandai M; Yamaguchi K
    Int Cancer Conf J; 2021 Jan; 10(1):46-53. PubMed ID: 33489701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mixed Ovarian Neoplasms With Gastrointestinal-type Mucinous and Mullerian Epithelial Components: A Rare Group of Tumors Demonstrating the Phenotypic Plasticity of the Mullerian Epithelial Cell.
    Chui MH; Ellenson LH
    Am J Surg Pathol; 2023 Jul; 47(7):756-765. PubMed ID: 37125505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation of Seromucinous Borderline Tumor from Serous Borderline Tumor on MR Imaging.
    Kurata Y; Kido A; Moribata Y; Kameyama K; Minamiguchi S; Konishi I; Togashi K
    Magn Reson Med Sci; 2018 Jul; 17(3):211-217. PubMed ID: 28993546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytological Appearances of Ovarian Seromucinous Borderline Tumor in Ascites: Presentation of 2 Cases.
    Kai K; Hashiguchi M; Kurihara M; Tanaka Y; Kitamura S; Nakamura M; Shichijo C; Yamamoto-Rikitake M; Okuma R; Hikari T; Okuma E; Uchiyama M; Aoki S; Nakao Y; Yokoyama M; Aishima S
    Acta Cytol; 2021; 65(5):440-447. PubMed ID: 34284376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian Seromucinous Borderline Tumor and Clear Cell Carcinoma: An Unusual Combination.
    Nakamura E; Sato Y; Moriguchi S; Yamashita A; Higo T; Asada Y
    Case Rep Obstet Gynecol; 2015; 2015():690891. PubMed ID: 26075120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PAX2 and PAX8 reliably distinguishes ovarian serous tumors from mucinous tumors.
    Wang M; Ma H; Pan Y; Xiao W; Li J; Yu J; He J
    Appl Immunohistochem Mol Morphol; 2015 Apr; 23(4):280-7. PubMed ID: 24992169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seromucinous borderline tumor of the testis-A case report.
    Scholz B; Beckert M; Mordstein V; Hohmann N; Walther R; Papadopoulos T
    Hum Pathol; 2017 Feb; 60():188-191. PubMed ID: 27597522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.